These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35636439)

  • 1. Immunisation status of UK-bound refugees between January, 2018, and October, 2019: a retrospective, population-based cross-sectional study.
    Deal A; Hayward SE; Crawshaw AF; Goldsmith LP; Hui C; Dalal W; Wurie F; Bautista MA; Lebanan MA; Agan S; Hassan FA; Wickramage K; Campos-Matos I; Hargreaves S
    Lancet Public Health; 2022 Jul; 7(7):e606-e615. PubMed ID: 35636439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018.
    Mellou K; Silvestros C; Saranti-Papasaranti E; Koustenis A; Pavlopoulou ID; Georgakopoulou T; Botsi C; Terzidis A
    Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphtheria-Tetanus-Polio, Measles-Mumps-Rubella, and Hepatitis B Vaccination Coverage and Associated Factors among Homeless Children in the Paris Region in 2013: Results from the ENFAMS Survey.
    Mansor-Lefebvre S; Le Strat Y; Bernadou A; Vignier N; Guthmann JP; Arnaud A; Lévy-Bruhl D; Vandentorren S
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326203
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination status and needs of asylum-seeking children in Denmark: a retrospective data analysis.
    Nakken CS; Skovdal M; Nellums LB; Friedland JS; Hargreaves S; Norredam M
    Public Health; 2018 May; 158():110-116. PubMed ID: 29653865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone.
    Wassenaar M; Fombah AE; Chen H; Owusu-Kyei K; Williams J; Sunders JC; Llach M; Quinto L; Sesay T; Samai M; Menéndez C; González R
    BMC Public Health; 2024 Jan; 24(1):143. PubMed ID: 38200476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the views of adult migrants around catch-up vaccination for missed routine immunisations to define strategies to improve coverage: A UK in-depth interview study.
    Deal A; Crawshaw AF; Salloum M; Hayward SE; Carter J; Knights F; Seedat F; Bouaddi O; Sanchez-Clemente N; Muzinga Lutumba L; Mimi Kitoko L; Nkembi S; Hickey C; Mounier-Jack S; Majeed A; Hargreaves S
    Vaccine; 2024 May; 42(13):3206-3214. PubMed ID: 38631950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring electronic health records to estimate the extent of catch-up immunisation and factors associated with under-immunisation among refugees and asylum seekers in south east Queensland.
    Nyanchoga MM; Lee P; Barbery G
    Vaccine; 2021 Oct; 39(42):6238-6244. PubMed ID: 34556368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study.
    Feldstein LR; Bennett SD; Estivariz CF; Cooley GM; Weil L; Billah MM; Uzzaman MS; Bohara R; Vandenent M; Adhikari JM; Leidman E; Hasan M; Akhtar S; Hasman A; Conklin L; Ehlman D; Alamgir A; Flora MS
    PLoS Med; 2020 Mar; 17(3):e1003071. PubMed ID: 32231368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of measles containing vaccines in the measles, mumps, and rubella second dose catch-up programme in Wales.
    Thomas DR; King J; Evans MR; Salmon RL
    Commun Dis Public Health; 1998 Mar; 1(1):44-7. PubMed ID: 9718839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zero-dose children and the extended immunisation cascade: Understanding the path to full immunisation with six childhood vaccines in 43 countries.
    Cata-Preta BO; Silva LAN; Costa FS; Santos TM; Mengistu T; Hogan DR; Victora CG; Barros AJ
    J Glob Health; 2024 Sep; 14():04199. PubMed ID: 39325925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent immunizations: missed opportunities for prevention.
    Lee GM; Lorick SA; Pfoh E; Kleinman K; Fishbein D
    Pediatrics; 2008 Oct; 122(4):711-7. PubMed ID: 18829792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.
    Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A
    Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination coverage in Lebanon following the Syrian crisis: results from the district-based immunization coverage evaluation survey 2016.
    Mansour Z; Hamadeh R; Rady A; Danovaro-Holliday MC; Fahmy K; Said R; Brandt L; Warrak R; Ammar W
    BMC Public Health; 2019 Jan; 19(1):58. PubMed ID: 30642314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-specific immunological effects of selected routine childhood immunisations: systematic review.
    Kandasamy R; Voysey M; McQuaid F; de Nie K; Ryan R; Orr O; Uhlig U; Sande C; O'Connor D; Pollard AJ
    BMJ; 2016 Oct; 355():i5225. PubMed ID: 27737830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017.
    Hargreaves S; Nellums LB; Ravensbergen SJ; Friedland JS; Stienstra Y;
    Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single doses of diphtheria-tetanus-pertussis and poliomyelitis vaccines are sufficient to generate a booster-type response to tetanus in most migrant children.
    Fougère Y; El Houss S; Suris JC; Rouvenaz-Defago S; Miletto D; Von der Weid L; Willen F; Williams-Smith JA; Gehri M; Crisinel PA
    Vaccine; 2019 Oct; 37(43):6441-6446. PubMed ID: 31522805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.